Obesity is a major risk factor for some of the leading causes of death worldwide. Glucagon-like peptide-1 or GLP-1 antagonists have seen their popularity rise in the last few years in the treatment of obesity and type 2 diabetes mellitus (T2DM).
What is orforglipron?
- Aug 9, 2023